Carleton R Sage

Title: Carleton R. Sage: Innovator in Metabolic Disorders

Introduction

Carleton R. Sage is a prominent inventor based in Encinitas, California. He has made significant contributions to the field of metabolic disorders through his innovative research and development of therapeutic compounds. With a total of 4 patents, Sage's work focuses on addressing various health issues related to weight management and metabolic conditions.

Latest Patents

One of Sage's latest patents involves 5-HT receptor agonists and compositions and methods of use. This invention provides compounds that can be utilized for weight management, inducing satiety, and decreasing food intake. It also addresses the prevention and treatment of obesity, type 2 diabetes, and various psychiatric disorders, among other health issues. Another notable patent includes fused-aryl and heteroaryl derivatives as modulators of metabolism, which are useful in the prophylaxis and treatment of metabolic disorders such as diabetes and obesity.

Career Highlights

Carleton R. Sage is currently associated with Arena Pharmaceuticals, Inc., where he continues to advance his research in metabolic health. His work has been instrumental in developing new therapeutic approaches that target complex health challenges.

Collaborations

Sage has collaborated with notable colleagues, including Graeme Semple and Albert S. Ren, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Carleton R. Sage's contributions to the field of metabolic disorders through his patents and research at Arena Pharmaceuticals, Inc. highlight his role as a key innovator in addressing significant health challenges. His work continues to pave the way for advancements in treatment options for various metabolic conditions.